Association of Derived Neutrophil-To-Lymphocyte Ratio With Prognosis of Coronary Heart Disease After PCI

Gang-Qiong Liu1, Wen-Jing Zhang1, Jia-Hong Shangguan1,2

  • 1Department of Cardiology, Key Laboratory of Cardiac Injury and Repair of Henan Province, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Insights

The derived neutrophil-to-lymphocyte ratio (dNLR) predicts mortality in coronary heart disease (CHD) patients post-PCI. Higher dNLR levels correlate with increased risks of all-cause and cardiac mortality, indicating its prognostic value.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Research

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Percutaneous coronary intervention (PCI) is a common revascularization strategy for CHD.
  • Identifying reliable prognostic markers post-PCI is crucial for patient management.

Purpose of the Study:

  • To investigate the prognostic significance of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients with CHD following PCI.
  • To evaluate the association between dNLR tertiles and adverse outcomes, including mortality and major adverse cardiovascular events (MACEs).

Main Methods:

  • Retrospective analysis of 3,561 CHD patients undergoing PCI (CORFCHD-ZZ study, 2013-2017).
  • Patients stratified into three dNLR tertiles: <1.36, 1.36-1.96, and ≥1.96.
  • Primary endpoint: mortality (all-cause and cardiac death); Secondary endpoints: MACEs and MACCEs; Mean follow-up: 37.59 months.

Main Results:

  • Higher dNLR tertiles were associated with significantly increased all-cause mortality (ACM) and cardiac mortality (CM) in the overall cohort.
  • Multivariate analysis confirmed dNLR as an independent predictor: higher dNLR increased ACM risk by 1.763 times and CM risk by 1.961 times.
  • Significant differences in ACM incidence observed across dNLR tertiles in both acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) patients; CM differences were significant in CCS patients.

Conclusions:

  • The derived neutrophil-to-lymphocyte ratio (dNLR) serves as an independent and novel predictor of mortality in CHD patients after PCI.
  • dNLR stratification can aid in risk stratification and long-term management of post-PCI CHD patients.
  • Further research may explore therapeutic strategies targeting inflammation indicated by dNLR.